GSK PLC SP. ADR/2 NEW Financial Flexibility Index
GSK PLC SP. ADR/2 NEW financial flexibility index. GSK PLC SP. ADR/2 NEW (GS70) has a Financial Flexibility Index of 0.08x as of June 2026. Free cash flow of €3.34 Billion (operating CF €2.69 Billion minus capex €653.00 Million) represents 0% of total liabilities (€44.56 Billion). See GS70 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GSK PLC SP. ADR/2 NEW (2021–2025)
Financial flexibility index of GSK PLC SP. ADR/2 NEW from 2021 to 2025. Historical Financial Flexibility Index trend for GSK PLC SP. ADR/2 NEW across 5 annual periods. Check GSK PLC SP. ADR/2 NEW cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
GSK PLC SP. ADR/2 NEW Financial Flexibility Index by Year (2021–2025)
GSK PLC SP. ADR/2 NEW financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for GSK PLC SP. ADR/2 NEW. For the full cash flow conversion analysis, see GS70 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | €10.73 Billion | €7.74 Billion | €45.16 Billion | ▲ +15.5% |
| 2024 | 0.21x | €9.54 Billion | €6.55 Billion | €46.38 Billion | ▲ +4.3% |
| 2023 | 0.20x | €9.11 Billion | €6.77 Billion | €46.21 Billion | ▲ +2.2% |
| 2022 | 0.19x | €9.66 Billion | €7.40 Billion | €50.05 Billion | ▲ +5.1% |
| 2021 | 0.18x | €10.61 Billion | €7.95 Billion | €57.76 Billion | — |